VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,268 | -10.6% | 9,486 | 0.0% | 0.06% | -3.2% |
| Q2 2023 | $285,623 | -8.4% | 9,486 | -1.5% | 0.06% | -12.7% |
| Q1 2023 | $311,799 | +13.5% | 9,626 | 0.0% | 0.07% | +10.9% |
| Q4 2022 | $274,637 | +32.7% | 9,626 | +12.8% | 0.06% | +39.1% |
| Q3 2022 | $207,000 | -11.5% | 8,530 | 0.0% | 0.05% | -9.8% |
| Q2 2022 | $234,000 | -30.4% | 8,530 | -2.6% | 0.05% | -22.7% |
| Q1 2022 | $336,000 | -8.2% | 8,755 | -23.4% | 0.07% | -1.5% |
| Q4 2021 | $366,000 | +38.6% | 11,424 | +27.7% | 0.07% | +31.4% |
| Q3 2021 | $264,000 | +22.2% | 8,945 | +41.0% | 0.05% | +15.9% |
| Q2 2021 | $216,000 | -28.9% | 6,345 | -32.1% | 0.04% | -32.3% |
| Q1 2021 | $304,000 | +32.8% | 9,345 | +47.3% | 0.06% | +25.0% |
| Q4 2020 | $229,000 | -7.7% | 6,345 | 0.0% | 0.05% | -8.8% |
| Q3 2020 | $248,000 | -73.9% | 6,345 | -75.6% | 0.06% | -68.5% |
| Q2 2020 | $952,000 | +34.3% | 25,951 | -12.8% | 0.18% | +17.5% |
| Q1 2020 | $709,000 | +50.9% | 29,744 | +85.9% | 0.15% | +63.8% |
| Q4 2019 | $470,000 | -8.9% | 15,996 | -17.3% | 0.09% | -21.0% |
| Q3 2019 | $516,000 | +132.4% | 19,336 | +121.6% | 0.12% | +142.9% |
| Q2 2019 | $222,000 | +20.0% | 8,725 | +6.1% | 0.05% | +6.5% |
| Q1 2019 | $185,000 | +6.9% | 8,225 | 0.0% | 0.05% | -6.1% |
| Q4 2018 | $173,000 | +17200.0% | 8,225 | +27316.7% | 0.05% | – |
| Q3 2018 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -99.9% | 30 | -100.0% | 0.00% | -100.0% |
| Q1 2018 | $1,484,000 | -2.8% | 67,495 | +2.8% | 0.39% | -9.0% |
| Q4 2017 | $1,527,000 | +872.6% | 65,671 | +863.3% | 0.43% | +802.1% |
| Q3 2017 | $157,000 | +6.8% | 6,817 | 0.0% | 0.05% | +4.3% |
| Q2 2017 | $147,000 | +14600.0% | 6,817 | +22623.3% | 0.05% | – |
| Q1 2017 | $1,000 | -98.5% | 30 | -99.0% | 0.00% | -100.0% |
| Q4 2016 | $66,000 | -54.2% | 3,130 | -42.6% | 0.02% | -59.0% |
| Q3 2016 | $144,000 | -33.9% | 5,450 | -30.9% | 0.06% | -33.0% |
| Q2 2016 | $218,000 | – | 7,885 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |